v1
CCK-B/Gastrin receptor transmembrane domain mutations selectively alter synthetic agonist efficacy without affecting the activity of endogenous peptides.
- NobleID
- NI9P49W19R07S34
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/B2DA7DCB
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims